| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0003 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0004 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | -0.18 | 0.0004 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0004 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.1 | 0.0004 |